HSAQ
Income statement / Annual
Last year (2024), Health Sciences Acquisitions Corporation 2's total revenue was $2.64 M,
and the percentage change from the previous year is not available.
In 2024, Health Sciences Acquisitions Corporation 2's net income was -$61.02 M.
See Health Sciences Acquisitions Corporation 2,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$2.64 M |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$204.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$2.43 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.92
|
0
|
0
|
0
|
| Research and Development Expenses |
$42.80 M
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$2.96 M
|
$274.76 K
|
$129.99 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$23.93 M
|
$2.96 M
|
$274.76 K
|
$129.99 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$50.00 K
|
| Operating Expenses |
$66.74 M
|
$2.96 M
|
$274.76 K
|
$179.99 K
|
| Cost And Expenses |
$66.94 M
|
$2.96 M
|
$274.76 K
|
$179.99 K
|
| Interest Income |
$0.00
|
$345.14 K
|
$16.00 K
|
$0.00
|
| Interest Expense |
$0.00
|
-$345.14 K
|
-$16.00 K
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$345.14 K
|
$16.00 K
|
$206.30 K
|
| EBITDA |
-$64.30 M |
-$2.74 M |
-$378.75 K |
-$173.54 K |
| EBITDA Ratio |
-24.37
|
0
|
0
|
0
|
| Operating Income Ratio |
-24.37
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$3.28 M
|
$345.14 K
|
$16.00 K
|
$0.00
|
| Income Before Tax |
-$61.02 M
|
-$2.74 M
|
-$378.75 K
|
-$173.54 K
|
| Income Before Tax Ratio |
-23.13
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$345.14 K
|
-$16.00 K
|
$0.00
|
| Net Income |
-$61.02 M
|
-$2.39 M
|
-$362.75 K
|
-$173.54 K
|
| Net Income Ratio |
-23.13
|
0
|
0
|
0
|
| EPS |
-1.66 |
-0.15 |
-0.0179 |
-0.0086 |
| EPS Diluted |
-1.66 |
-0.15 |
-0.0179 |
-0.0086 |
| Weighted Average Shares Out |
$36.82 B
|
$16.43 M
|
$20.27 M
|
$20.27 M
|
| Weighted Average Shares Out Diluted |
$36.82 B
|
$16.43 M
|
$20.27 M
|
$20.27 M
|
| Link |
|
|
|
|
